7814.TWO · HORIEN
Taiwan · RS rating 4 · As of 2026-10-08
| Price | 28.50 TWD |
|---|---|
| 1-day change | +1.8% |
| RS rating (overall / 1M / 3M / 12M) | 4 / 34 / 4 / 9 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 32 / 15 / 42 |
| Industry group (rank) | Medical-Biomed/Biotech (53) |
| EPS growth Q/Q | +97.4% |
| Sales growth Q/Q | +4.0% |
| Distance from 52-week high | +36.3% |
| Market cap (USD) | $39.7M |